Patients with diabetes controlled with oral hypoglycemic agents (DM-oral) and those with insulin-controlled diabetes (DM-insulin) are both at a higher risk of AKI following cardiac surgery than the non-diabetic population (adjusted odds ratios: DM-oral = 1.26, DM-insulin = 3.92, [18]). This evidence concerns the gene INS and acute kidney injury.